NEW YORK --(BUSINESS WIRE)--Jan. 10, 2024-- DocGo Inc. (“DocGo” or the “Company”) categorically rejects this purported assessment by Fuzzy Panda Research , an obscure short seller motivated solely by profit. Their so-called “research report” uses what appears to be old, public information to
